Application Process
The official application process can be found below. Please read and verify your availability before submitting your application.
Golden Ticket Benefits
Eligibility Snapshot
This new edition of the « Golden Ticket » program Amgen – Biolabs Hôtel-Dieu in Paris is open to life sciences, biotechnology and digital health startups that are developing innovative solutions in:
Cardiovascular and metabolic diseases, rare diseases, inflammatory diseases, oncology and hematology
Emerging approach and technology platforms in the fields of R&D, precision medicine or data sciences (link with AI, organoids …)
Providing added value in health activities
The Application Process
01
Submit the online application by October 7, 2024
02
A subset of applications will be identified as finalist by the contest judges by
November 10, 2024
03
Finalists will present their company & scientific concept at an in-person event on
December 10, 2024
04
Two awards will be granted
Good luck!
Judging Criteria and Judges
The Committees will judge all Applications based on the following criteria:
Quality of the science and scientific rationale: description of the scientific rationale and of the unique technical features of the proposed solution, summary of proof-of-concept data
Strategic alignment with Amgen’s current therapeutic areas
Need and development potential in the applicable field (i) description of the problem/unmet need that the technology addresses and of the adequation of the proposed solution to the unmet need and (ii) description of the differentiation of the proposed solution within the international competitive landscape;
Execution capabilities of the Participant’s team: background of the founders, description of the composition of the participant’s team
Sustainability and impact of the Participant’s activities on the environment and society
Interest and motivation to join BioLabs Hôtel Dieu site
Contact Us
If you have any questions about this Golden Ticket, contact:
If you have any questions about BioLabs or Golden tickets in general, contact: